SCHEMBL720310

SCHEMBL720310

CCCCCCCCCC(O)(OCC)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.41
GAA P10253 1/20 0.40
SCN5A Q14524 3/20 0.40
SCN9A Q15858 3/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
CHRM2 P08172 2/20 0.37
CHRM3 P20309 2/20 0.37
ATM Q13315 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
EBP Q15125 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27796449 0.79 SIGMAR1 (0.41) SIGMAR1GAAMEN1KMT2ACHRM2
SCHEMBL720308 0.79 CNR1 (0.36) SIGMAR1GAASCN5ASCN9AMEN1
SCHEMBL3972776 0.78 SIGMAR1 (0.37) SIGMAR1GAASCN5ASCN9AMEN1
SCHEMBL6755985 0.77 LTA4H (0.37) SIGMAR1GAAMEN1KMT2ACNR1
SCHEMBL9782412 0.77 SIGMAR1 (0.46) SIGMAR1GAASCN5ASCN9AMEN1
SCHEMBL5395161 0.77 SIGMAR1 (0.64) SIGMAR1GAASCN5ASCN9ACHRM2
SCHEMBL3809940 0.77 SIGMAR1 (0.46) SIGMAR1GAASCN5ASCN9AMEN1
SCHEMBL6471777 0.77 SIGMAR1 (0.46) SIGMAR1GAASCN5ASCN9AMEN1
SCHEMBL3422456 0.77 SIGMAR1 (0.46) SIGMAR1GAASCN5ASCN9AMEN1
SCHEMBL11413546 0.77 SIGMAR1 (0.64) SIGMAR1GAASCN5ASCN9ACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438166-B1 METHOD FOR PREPARING PROTEIN, DNA, AND RNA FROM CELL CANON KK (JP) 2015-11-11 EP disclosed
US-9169480-B2 Method for preparing protein, DNA, and RNA from cell CANON KABUSHIKI KAISHA (JP) 2015-10-27 US disclosed
EP-2438166-A1 METHOD FOR PREPARING PROTEIN, DNA, AND RNA FROM CELL Canon Kabushiki Kaisha (JP) 2012-04-11 EP disclosed
US-20120053329-A1 METHOD FOR PREPARING PROTEIN, DNA, AND RNA FROM CELL CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
WO-2010140598-A1 METHOD FOR PREPARING PROTEIN, DNA, AND RNA FROM CELL CANON KABUSHIKI KAISHA (JP) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053329-A1 METHOD FOR PREPARING PROTEIN, DNA, AND RNA FROM CELL DDX21, HNRNPR, NXF1 SIGMAR1 3744/4885GAA 3467/4885SCN5A 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.